nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Gemifloxacin—Fatigue—Gemcitabine—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Gastritis—Epirubicin—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Gemifloxacin—Pain—Gemcitabine—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Gemifloxacin—Constipation—Gemcitabine—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Gemifloxacin—Nausea—Erlotinib—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Gemifloxacin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Gemifloxacin—Diarrhoea—Sunitinib—pancreatic cancer	0.000704	0.000704	CcSEcCtD
Gemifloxacin—Dysgeusia—Docetaxel—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000701	0.000701	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Gemifloxacin—Dysphagia—Epirubicin—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Gemifloxacin—Back pain—Docetaxel—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Gemifloxacin—Pain—Fluorouracil—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000694	0.000694	CcSEcCtD
Gemifloxacin—Muscle spasms—Docetaxel—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Gemifloxacin—Eosinophilia—Epirubicin—pancreatic cancer	0.000689	0.000689	CcSEcCtD
Gemifloxacin—Pancreatitis—Epirubicin—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Gemifloxacin—Dizziness—Sunitinib—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Gemifloxacin—Breast disorder—Doxorubicin—pancreatic cancer	0.000673	0.000673	CcSEcCtD
Gemifloxacin—Abdominal pain—Irinotecan—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Gemifloxacin—Body temperature increased—Irinotecan—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Gemifloxacin—Anaemia—Docetaxel—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Gemifloxacin—Gastritis—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000657	0.000657	CcSEcCtD
Gemifloxacin—Vomiting—Sunitinib—pancreatic cancer	0.000655	0.000655	CcSEcCtD
Gemifloxacin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000653	0.000653	CcSEcCtD
Gemifloxacin—Rash—Sunitinib—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Gemifloxacin—Dermatitis—Sunitinib—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Gemifloxacin—Urticaria—Fluorouracil—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Gemifloxacin—Headache—Sunitinib—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Gemifloxacin—Syncope—Docetaxel—pancreatic cancer	0.000644	0.000644	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Gemifloxacin—Leukopenia—Docetaxel—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Gemifloxacin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Palpitations—Docetaxel—pancreatic cancer	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000631	0.000631	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000631	0.000631	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—pancreatic cancer	0.000624	0.000624	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—pancreatic cancer	0.00062	0.00062	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—pancreatic cancer	0.00062	0.00062	CcSEcCtD
Gemifloxacin—Myalgia—Docetaxel—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gemifloxacin—Arthralgia—Docetaxel—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gemifloxacin—Nausea—Sunitinib—pancreatic cancer	0.000612	0.000612	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Gemifloxacin—Asthenia—Irinotecan—pancreatic cancer	0.000609	0.000609	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000608	0.000608	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Gemifloxacin—Dry mouth—Docetaxel—pancreatic cancer	0.000598	0.000598	CcSEcCtD
Gemifloxacin—Asthenia—Gemcitabine—pancreatic cancer	0.000593	0.000593	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Oedema—Docetaxel—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Pruritus—Gemcitabine—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Gemifloxacin—Diarrhoea—Irinotecan—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000579	0.000579	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Gemifloxacin—Shock—Docetaxel—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Gemifloxacin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000575	0.000575	CcSEcCtD
Gemifloxacin—Pruritus—Fluorouracil—pancreatic cancer	0.000575	0.000575	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—pancreatic cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Tachycardia—Docetaxel—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Gemifloxacin—Skin disorder—Docetaxel—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Gemifloxacin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—pancreatic cancer	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Gemifloxacin—Dizziness—Irinotecan—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Gemifloxacin—Anorexia—Docetaxel—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Gemifloxacin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000556	0.000556	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—pancreatic cancer	0.000552	0.000552	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00055	0.00055	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—pancreatic cancer	0.000547	0.000547	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000547	0.000547	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—pancreatic cancer	0.000546	0.000546	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Gemifloxacin—Vomiting—Irinotecan—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—pancreatic cancer	0.000537	0.000537	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Gemifloxacin—Rash—Irinotecan—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Gemifloxacin—Dermatitis—Irinotecan—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Gemifloxacin—Headache—Irinotecan—pancreatic cancer	0.000531	0.000531	CcSEcCtD
Gemifloxacin—Insomnia—Docetaxel—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000526	0.000526	CcSEcCtD
Gemifloxacin—Vomiting—Gemcitabine—pancreatic cancer	0.000525	0.000525	CcSEcCtD
Gemifloxacin—Dyspnoea—Docetaxel—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Gemifloxacin—Somnolence—Docetaxel—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Gemifloxacin—Rash—Gemcitabine—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Gemifloxacin—Dermatitis—Gemcitabine—pancreatic cancer	0.00052	0.00052	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—pancreatic cancer	0.00052	0.00052	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Gemifloxacin—Headache—Gemcitabine—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Gemifloxacin—Dyspepsia—Docetaxel—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000515	0.000515	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Gemifloxacin—Decreased appetite—Docetaxel—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Gemifloxacin—Fatigue—Docetaxel—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Gemifloxacin—Nausea—Irinotecan—pancreatic cancer	0.000504	0.000504	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000502	0.000502	CcSEcCtD
Gemifloxacin—Pain—Docetaxel—pancreatic cancer	0.000501	0.000501	CcSEcCtD
Gemifloxacin—Constipation—Docetaxel—pancreatic cancer	0.000501	0.000501	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—pancreatic cancer	0.000496	0.000496	CcSEcCtD
Gemifloxacin—Nausea—Gemcitabine—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000487	0.000487	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—pancreatic cancer	0.000483	0.000483	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—pancreatic cancer	0.000477	0.000477	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—pancreatic cancer	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—pancreatic cancer	0.000466	0.000466	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000464	0.000464	CcSEcCtD
Gemifloxacin—Abdominal pain—Docetaxel—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Gemifloxacin—Body temperature increased—Docetaxel—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—pancreatic cancer	0.000442	0.000442	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000431	0.000431	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Gemifloxacin—Asthenia—Docetaxel—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Gemifloxacin—Pruritus—Docetaxel—pancreatic cancer	0.000415	0.000415	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Gemifloxacin—Diarrhoea—Docetaxel—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—pancreatic cancer	0.000396	0.000396	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000394	0.000394	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Gemifloxacin—Dizziness—Docetaxel—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—pancreatic cancer	0.000386	0.000386	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—pancreatic cancer	0.000384	0.000384	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—pancreatic cancer	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—pancreatic cancer	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000379	0.000379	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Gemifloxacin—Vomiting—Docetaxel—pancreatic cancer	0.000373	0.000373	CcSEcCtD
Gemifloxacin—Rash—Docetaxel—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Gemifloxacin—Dermatitis—Docetaxel—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Gemifloxacin—Headache—Docetaxel—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000358	0.000358	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—pancreatic cancer	0.000358	0.000358	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—pancreatic cancer	0.000357	0.000357	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—pancreatic cancer	0.000355	0.000355	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000354	0.000354	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—pancreatic cancer	0.000353	0.000353	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—pancreatic cancer	0.000349	0.000349	CcSEcCtD
Gemifloxacin—Nausea—Docetaxel—pancreatic cancer	0.000348	0.000348	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—pancreatic cancer	0.000348	0.000348	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—pancreatic cancer	0.000331	0.000331	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—pancreatic cancer	0.000325	0.000325	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000323	0.000323	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000322	0.000322	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000318	0.000318	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000316	0.000316	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—pancreatic cancer	0.000315	0.000315	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—pancreatic cancer	0.000314	0.000314	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—pancreatic cancer	0.000313	0.000313	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000299	0.000299	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—pancreatic cancer	0.000291	0.000291	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000289	0.000289	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000289	0.000289	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—pancreatic cancer	0.000284	0.000284	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—pancreatic cancer	0.00028	0.00028	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—pancreatic cancer	0.000271	0.000271	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—pancreatic cancer	0.000263	0.000263	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—pancreatic cancer	0.000262	0.000262	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—pancreatic cancer	0.000259	0.000259	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—pancreatic cancer	0.000251	0.000251	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—pancreatic cancer	0.00025	0.00025	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—pancreatic cancer	0.000249	0.000249	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—pancreatic cancer	0.000249	0.000249	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—pancreatic cancer	0.000248	0.000248	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—pancreatic cancer	0.000242	0.000242	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—pancreatic cancer	0.000235	0.000235	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—pancreatic cancer	0.000233	0.000233	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—pancreatic cancer	0.000231	0.000231	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—pancreatic cancer	0.00023	0.00023	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—pancreatic cancer	0.000229	0.000229	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—pancreatic cancer	0.000217	0.000217	CcSEcCtD
